nach oben

Clinical Rheumatology

Erschienen in:

26.07.2017 | Original Article

Decreased olfactory bulb volumes in patients with fibromyalgia syndrome

verfasst von: Selçuk Sayılır, Neşat Çullu

Erschienen in: Clinical Rheumatology | Ausgabe 12/2017

Einloggen, um Zugang zu erhalten

Abstract

Among the other symptoms, impaired olfactory function such as odor identification, threshold, and discrimination have been reported in patients with fibromyalgia syndrome (FMS). To investigate olfactory bulb (OB) volumes in FMS, by using magnetic resonance imaging (MRI), and to make reasonable suggestions are the goals of the present study. The study included 62 individuals as the FMS group (n = 30) and the control group (n = 32). MRI examinations were performed by a 1.5-T scanner and a standard head coil was used for the images. The coronal T2-weighted images were used for to measure OB volumes. Right, left, and total OB volumes were calculated with the aid of these images. The mean age of the FMS group was 44.2 ± 8.3 years and the control group was 41.7 ± 3.53 years. The mean volume of the right OB was 74.9 ± 12.4 mm³ in the FMS group and was 92.6 ± 12.9 mm³ in the control group. The mean value of the left OB volume was 74.3 ± 10.8 mm³ in the FMS group and 92.8 ± 12.6 mm³ in the control group. The mean of the total OB volume was 146.6 ± 20.81 mm³ in the FMS group and 186.5 ± 23.5 mm³ in the control group. Left, right, and total OB volumes were significantly lower in the FMS group than in the control group (all p < 0.05). Female patients with FMS are under the risk of the decreased olfactory bulb volumes. This situation should be kept in mind for proper and reasonable management of this tough syndrome.

Williams DA, Clauw DJ (2009) Understanding fibromyalgia: lessons from the broader pain research community. J Pain 10:777–791CrossRefPubMedPubMedCentral

Koklu K, Sarıgul M, Ozisler Z, Sirzai H, Ozel S (2016) Handgrip strength in fibromyalgia. Arch Rheumatol 31:158–161CrossRef

Branco JC et al (2010) Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 39:448–453CrossRefPubMed

Yazmalar L et al (2016) High frequency of fibromyalgia in patients with acne vulgaris. Arch Rheumatol 31:170–175CrossRef

Buschhüter D et al (2008) Correlation between olfactory bulb volume and olfactory function. NeuroImage 42:498–502CrossRefPubMed

Doty RL (2012) Olfaction in Parkinson’s disease and related disorders. Neurobiol Dis 46:527–552CrossRefPubMed

Moberg PJ et al (2013) Meta-analysis of olfactory function in schizophrenia, first degree family members, and youths at-risk for psychosis. Schizophr Bull 40:50–59CrossRefPubMedPubMedCentral

Ortega-Hernandez OD, Kivity S, Shoenfeld Y (2009) Olfaction, psychiatricdisorders and autoimmunity: is there a common geneticassociation. Autoimmunity 42:80–88CrossRefPubMed

Demarquay G, Ryvlin P, Royet JP (2007) Olfaction and neurological diseases: a review of the literature. Rev Neurol (Paris) 163:155–167CrossRef

10.

Strous RD, Shoenfeld Y (2006) To smell the immune system: olfaction, autoimmunity and brain involvement. Autoimmun Rev 6:54–60CrossRefPubMed

11.

Leon-Sarmiento FE, Bayona EA, Bayona-Prieto J, Osman A, Doty RL (2012) Profound olfactory dysfunction in myasthenia gravis. PLoS One 7:e45544CrossRefPubMedPubMedCentral

12.

Shoenfeld Y (2007) To smell autoimmunity: anti-P-ribosomal autoantibodies, depression, and the olfactory system. J Autoimmun 28:165–169CrossRefPubMed

13.

Rombaux P, Duprez T, Hummel T (2009) Olfactory bulb volume in the clinical assessment of olfactory dysfunction. Rhinology 47:3–9PubMed

14.

Mueller A et al (2005) Olfactory bulb volumes in patients with idiopathic Parkinson’s disease a pilot study. J Neural Transm 112:1363–1370CrossRefPubMed

15.

Wilbarger JL, Cook DB (2011) Multisensory hypersensitivity in women with fibromyalgia: implications for well being and intervention. Arch Phys Med Rehabil 92:653–656CrossRefPubMedPubMedCentral

16.

Jörn L, Hans-Georg K, Jörg W, Thomas H (2012) Self-ratings of higher olfactory acuity contrast with reduced olfactory test results offibromyalgia patients. Int J Psychophysiol 86:182–186CrossRef

17.

Howard A, Nancy AL (2014) Olfactory impairment in patients with thefibromyalgia syndrome and systemic sclerosis. Immunol Res 60:201–207CrossRef

18.

Burgmer M et al (2012) Cerebral mechanisms of experimental hyperalgesia in fibromyalgia. Eur J Pain 16:636–647CrossRefPubMed

19.

Staud R (2011) Brain imaging in fibromyalgia syndrome. Clin Exp Rheumatol 29:109–117

20.

Schweinhardt P, Sauro KM, Bushnell MC (2008) Fibromyalgia: a disorder of the brain. Neuroscientist 14:415–421CrossRefPubMed

21.

Lutz J et al (2008) White and gray matter abnormalities in the brain of patients with fibromyalgia: a diffusion-tensor and volumetric imaging study. Arthritis Rheum 58:3960–3969CrossRefPubMed

22.

Kuchinad A, Schweinhardt P, Seminowicz DA, Wood PB, Chizh BA, Bushnell MC (2007) Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain. J Neurosci 27:4004–4007CrossRefPubMed

23.

Burgmer M et al (2009) Decreased gray matter volumes in the cingulo-frontal cortex and the amygdala in patients with fibromyalgia. Psychosom Med 71(5):566–573CrossRefPubMed

24.

Martines-Marcos A (2009) On the organization of olfactory and vomeronasal cortices. Prog Neurobiol 87(1):21–30CrossRef

25.

Arnold LM et al (2006) Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 67(8):1219–1225CrossRefPubMed

26.

Sayılır S (2016) The relationship between symptom severity and cognitive functions of fibromyalgia syndrome with obesity. Turk J Osteoporos 22:129–131

27.

Negoias S et al (2010) Reduced olfactory bulb volume and olfactory sensitivity in patients with acute major depression. Neuroscience 169(1):415–421CrossRefPubMed

28.

Drevets WC (1999) Prefrontal cortical-amygdalar metabolism in major depression. Ann N Y Acad Sci 877:614–637CrossRefPubMed

29.

Drevets WC, Bogers W, Raichle ME (2002) Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharmacol 12:527–544CrossRefPubMed

30.

Wagner G, Koch K, Schachtzabel C, Reichenbach JR, Sauer H, Schlosser RG (2008) Enhanced rostral anterior cingulate cortex activation during cognitive control is related to orbitofrontal volume reduction in unipolar depression. J Psychiatry Neurosci 33:199–208PubMedPubMedCentral

31.

Song C, Leonard BE (2005) The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev 29:627–647CrossRefPubMed

32.

Taylor AG et al (2015) Stress, Inflammation and Pain: A Potential Role for Monocytes in Fibromyalgia-related Symptom Severity. Stress Health. doi:10.1002/smi.2648

33.

Bazzichi L et al (2007) Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol 25:225–230PubMed

34.

Selda B et al (2005) Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder. Rheumatol Int 25(3):188–190CrossRef

35.

Jill MR, Sarantopoulos CD (2009) Combined use of pregabalin and memantine in fibromyalgia syndrome treatment: a novel analgesic and neuroprotective strategy. Med Hypotheses 73:177–183CrossRef

Titel: Decreased olfactory bulb volumes in patients with fibromyalgia syndrome
verfasst von: Selçuk Sayılır
Neşat Çullu
Publikationsdatum: 26.07.2017
Verlag: Springer London
Erschienen in: Clinical Rheumatology / Ausgabe 12/2017
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-017-3772-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2017

Cardiovascular morbidity and mortality in patients with rheumatic disease: hyperuricemia, a forgotten puzzle piece?

Diagnostic performances of serum IgG4 concentration and IgG4/IgG ratio in IgG4-related disease

Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: a population-based study

Flares in Chinese systemic lupus erythematosus patients: a 6-year follow-up study

Effect of vitamin D supplementation in chronic widespread pain: a systematic review and meta-analysis